RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Role of liver transplantation in severe alcoholic hepatitis = Role of liver transplantation in severe alcoholic hepatitis

      한글로보기

      https://www.riss.kr/link?id=A105282148

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Severe alcoholic hepatitis has very high short term mortality and corticosteroids have been the mainstay of treatment for decades. Patients with Lille score >0.45 are considered non-responders to steroids and have poor outcome. Recently Orthotopic ...

      Severe alcoholic hepatitis has very high short term mortality and corticosteroids have been the mainstay of treatment for decades. Patients with Lille score >0.45 are considered non-responders to steroids and have poor outcome. Recently Orthotopic Liver Transplantation (OLT) is being increasingly used as rescue treatment for these patients, without waiting for 6 months of abstinence. Liver transplant is the only rescue treatment which can potentially provide long term benefit for patients who are steroid non-responders. However, with scarcity of organs being a concern, all patients of severe alcoholic hepatitis cannot be chosen for transplantation in an arbitrary way. There is a need for development of predictive tools and objective protocols to select patients who can justify the use of precious liver grafts. With a stringent criteria for selection of patients receiving the graft, liver transplantation in severe alcoholic hepatitis can become a viable rescue therapeutic option conferring significant survival advantage of both short- and long-term basis. The optimal criteria for selection will also prevent misuse of the liver donor pool as well as to prevent mortality in salvageable patients. Further research needs to be done to identify subset of patients which are at low risk of recidivism and also cannot be managed with pharmacotherapy alone. We reviewed the current knowledge on role of OLT in patient with acute severe alcoholic hepatitis in the present review. (Clin Mol Hepatol 2018;24:43-50)

      더보기

      참고문헌 (Reference)

      1 DiMartini A, "Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates" 24 : 1198-1201, 2000

      2 United Nations, "Universal Declaration of Human Rights"

      3 Mathurin P, "Trends in the management and burden of alcoholic liver disease" 62 (62): S38-S46, 2015

      4 O’Shea RS, "Treatment of alcoholic hepatitis" 9 : 103-134, 2005

      5 Brown RS Jr, "Transplantation for alcoholic hepatitis--time to rethink the 6-month "rule"" 365 : 1836-1838, 2011

      6 Lee BP, "Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis" 265 : 20-29, 2017

      7 Cohen JA, "The SGOT/SGPT ratio--an indicator of alcoholic liver disease" 24 : 835-838, 1979

      8 Louvet A, "The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids" 45 : 1348-1354, 2007

      9 Mathurin P, "Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone" 110 : 1847-1853, 1996

      10 Cabre E, "Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial" 32 : 36-42, 2000

      1 DiMartini A, "Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates" 24 : 1198-1201, 2000

      2 United Nations, "Universal Declaration of Human Rights"

      3 Mathurin P, "Trends in the management and burden of alcoholic liver disease" 62 (62): S38-S46, 2015

      4 O’Shea RS, "Treatment of alcoholic hepatitis" 9 : 103-134, 2005

      5 Brown RS Jr, "Transplantation for alcoholic hepatitis--time to rethink the 6-month "rule"" 365 : 1836-1838, 2011

      6 Lee BP, "Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis" 265 : 20-29, 2017

      7 Cohen JA, "The SGOT/SGPT ratio--an indicator of alcoholic liver disease" 24 : 835-838, 1979

      8 Louvet A, "The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids" 45 : 1348-1354, 2007

      9 Mathurin P, "Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone" 110 : 1847-1853, 1996

      10 Cabre E, "Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial" 32 : 36-42, 2000

      11 O’Keefee C, "Severe acute alcoholic hepatitis: an audit of medical treatment" 95 : 108-109, 2002

      12 Freeman RB, "Results of the first year of the new liver allocation plan" 10 : 7-15, 2004

      13 Dumortier J, "Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication" 110 : 1160-1166, 2015

      14 Freise CE, "Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study" 8 : 2569-2579, 2008

      15 Mendenhall CL, "Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis" 76 : 211-222, 1984

      16 Mendenhall CL, "Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275" 19 : 258-265, 1995

      17 Thursz MR, "Prednisolone or pentoxifylline for alcoholic hepatitis" 372 : 1619-1628, 2015

      18 Miguet M, "Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease" 28 (28): 845-851, 2004

      19 Park SH, "Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial" 61 : 792-798, 2014

      20 Akriviadis E, "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial" 119 : 1637-1648, 2000

      21 Singal AK, "Nutrition in alcoholic liver disease" 16 : 805-826, 2012

      22 Teran JC, "Nutrition and liver diseases" 1 : 335-340, 1999

      23 Papastergiou V, "Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort" 39 : 721-732, 2014

      24 Lucey MR, "Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases" 66 : 956-962, 1998

      25 Dew MA, "Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs" 14 : 159-172, 2008

      26 Mutimer DJ, "Managing severe alcoholic hepatitis complicated by renal failure" 86 : 649-656, 1993

      27 Shah VH, "Managing alcoholic liver disease" 21 : 212-219, 2015

      28 Pfitzmann R, "Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease" 13 : 197-205, 2007

      29 Iruzubieta P, "Long-term survival after liver transplantation for alcoholic liver disease" 19 : 9198-9208, 2013

      30 Burra P, "Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease" 13 (13): S174-S178, 2000

      31 Burra P, "Liver transplantation in alcoholic patients" 18 : 491-498, 2005

      32 Bonet H, "Liver transplantation for alcoholic liver disease: survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone" 17 : 1102-1106, 1993

      33 Hoofnagle JH, "Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland" 3 : 347-350, 1997

      34 McCallum S, "Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria" 41 : 358-363, 2006

      35 Belle SH, "Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995" 3 : 212-219, 1997

      36 Burra P, "Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry)" 10 : 138-148, 2010

      37 Varma V, "Liver transplantation for alcoholic liver disease" 16 : 4377-4393, 2010

      38 Hasanin M, "Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers" 21 : 1449-1452, 2015

      39 Nguyen-Khac E, "Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis" 365 : 1781-1789, 2011

      40 Naveau S, "Excess weight risk factor for alcoholic liver disease" 25 : 108-111, 1997

      41 Wiesner RH, "Evolving trends in liver transplantation: listing and liver donor allocation" 18 : 519-527, 2014

      42 Leong J, "Evaluation and selection of the patient with alcoholic liver disease for liver transplant" 16 : 851-863, 2012

      43 Donckier V, "Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy" 60 : 866-871, 2014

      44 MacFie J, "Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function" 16 : 606-611, 2000

      45 Bravata DM, "Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review" 7 : 191-203, 2001

      46 Louvet A, "Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids" 48 : 465-470, 2008

      47 Mathurin P, "Early liver transplantation for severe alcoholic hepatitis" 365 : 1790-1800, 2011

      48 Stroh G, "Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation" 15 : 1598-1604, 2015

      49 Im GY, "Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States-A Single-Center Experience" 16 : 841-849, 2016

      50 European Association for the Study of Liver, "EASL clinical practical guidelines: management of alcoholic liver disease" 57 : 399-420, 2012

      51 European Association for the Study of the Liver, "EASL Clinical Practice Guidelines: Liver transplantation" 64 : 433-485, 2016

      52 Mathurin P, "Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data" 60 : 255-260, 2011

      53 Maddrey WC, "Corticosteroid therapy of alcoholic hepatitis" 75 : 193-199, 1978

      54 Abecassis MM, "Complications of living donor hepatic lobectomy--a comprehensive report" 12 : 1208-1217, 2012

      55 Strieter RM, "Cellular and molecular regulation of tumor necrosis factoralpha production by pentoxifylline" 155 : 1230-1236, 1988

      56 Neuberger J, "Assessing priorities for allocation of donor liver grafts: survey of public and clinicians" 317 : 172-175, 1998

      57 Fabrega E, "Alcoholic recidivism after liver transplantation for alcoholic cirrhosis" 26 : 204-206, 1998

      58 Fabrega E, "Alcoholic recidivism after liver transplantation for alcoholic cirrhosis" 26 : 204-206, 1998

      59 Mendez-Sanchez N, "Alcoholic liver disease. An update" 4 : 32-42, 2005

      60 O'Shea RS, "Alcoholic liver disease" 51 : 307-328, 2010

      61 O’Shea RS, "Alcoholic liver disease" 105 : 14-32, 2010

      62 Lucey MR, "Alcoholic hepatitis" 360 : 2758-2769, 2009

      63 Cuadrado A, "Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease" 11 : 420-426, 2005

      64 Jesudian AB, "Acute alcoholic hepatitis as indication for liver transplantation" 21 : 107-110, 2016

      65 Fontana RJ, "Acute Liver Failure including Acetaminophen Overdose" 92 : 761-794, 2008

      66 Rice JP, "Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis" 19 : 1377-1386, 2013

      67 De Gottardi A, "A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years" 167 : 1183-1188, 2007

      68 Tandon P, "A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation" 104 : 1700-1706, 2009

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-06-18 학술지명변경 한글명 : The Korean Journal of Hepatology -> Clinical and Molecular Hepatology
      외국어명 : The Korean Journal of Hepatology -> Clinical and Molecular Hepatology
      KCI등재
      2011-01-18 학술지명변경 한글명 : 대한간학회지 -> The Korean Journal of Hepatology KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-04-10 학회명변경 영문명 : The Korean Association For The Study Of The Liver -> The korean Association for the Study of the Liver KCI등재후보
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-06-27 학술지명변경 외국어명 : The Korean Association for The Study of The Liver -> The Korean Journal of Hepatology KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.11 0.11 0.16
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.16 0.15 0.442 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼